Wrong Inventor Defense Fails in Pharmaceutical Litigation

Addressing derivation and obviousness issues, the US Court of Appeals for the Federal Circuit affirmed the district court’s denial of a generic drug…
Go to Source
Author: McDermott Will & Emery

WordPress Video Lightbox
Cerca